<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03476941</url>
  </required_header>
  <id_info>
    <org_study_id>201703759</org_study_id>
    <nct_id>NCT03476941</nct_id>
  </id_info>
  <brief_title>Antibiotic Irrigations for Intra-Abdominal Drains</brief_title>
  <acronym>AID</acronym>
  <official_title>Antibiotic Irrigations for Intra-Abdominal Drains</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Paolo Goffredo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intra-abdominal abscesses are pus-filled pouches in the abdominal cavity. Current standard of
      care includes drain placement in the abscess cavity to reach source control as well as
      administration of systemic antibiotics. It is common practice to flush the drain on a daily
      basis to ensure patency. This study aims to analyze the clinical impact of a higher local
      concentration of antibiotics (rather than normal saline) provided through drain irrigation
      with an antimicrobial agent (Gentamicin and/or Clindamycin) compare to normal saline.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      People with an abdominal abscess who undergo drain placement will have those drains irrigated
      twice/day with either normal saline (placebo group) or with the above antibiotic solution for
      a total of 7 days or less if the drain were to be removed earlier. Outcomes of interest are
      duration of systemic antibiotics, and WBC and temperature curve.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2018</start_date>
  <completion_date type="Anticipated">September 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>There will be two group, study and control group. In control group, patient will receive standard intra-abdominal drain care with daily flushing of the drain with normal saline. In study group, patient will receive daily flush with antibiotic for 7 days.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>We will obtain consent from the participants. Then, each participants will be randomized into two groups. Nurse will administer the drain flush either with normal saline or antibiotic irrigation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of systemic antibiotics</measure>
    <time_frame>From initiation of systemic treatment until 1 month follow up</time_frame>
    <description>This will be measured as days from diagnosis to when the antibiotic treatment gets interrupted.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>White Blood Count</measure>
    <time_frame>From initiation of systemic treatment until 1 month follow up</time_frame>
    <description>This will be measured daily as inpatient.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Temperature</measure>
    <time_frame>From initiation of systemic treatment until 1 month follow up</time_frame>
    <description>Vitals will be taken every 8 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in size of the Abscess</measure>
    <time_frame>From patient initial hospitalization up to 1 month follow up</time_frame>
    <description>Will review CT scans and other image modalities that relates to assessing changes in size of the abscess</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Drain Output</measure>
    <time_frame>From the drain placement up to 1 month follow up</time_frame>
    <description>Drain outputs recorded during inpatient care and follow up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of drain</measure>
    <time_frame>From the drain placement until 1 month follow up</time_frame>
    <description>Will assess days that drain remains in place</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Abdominal Abscess</condition>
  <arm_group>
    <arm_group_label>Antibiotic Irrigation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The drain will be irrigated twice/day with the above antibiotic solution for 7 days maximum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Saline Irrigation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The drain will be irrigated twice/day with normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gentamicin Sulfate Inj 20mg/2ml vial for injection</intervention_name>
    <description>Irrigate surgical drain with total amount of 5 mg in 10 ml volume twice/day for 7 days or until drain removal if less than 7 days of therapy.</description>
    <arm_group_label>Antibiotic Irrigation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clindamycin phosphate 6 mg/1ml for injection</intervention_name>
    <description>Irrigate surgical drain with total amount of 12 mg in 10 ml volume once daily for 7 days or until drain removal if less than 7 days of therapy.</description>
    <arm_group_label>Antibiotic Irrigation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>The placebo group will receive drain irrigation twice/day</description>
    <arm_group_label>Normal Saline Irrigation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Intra-abdominal abscess drained with catheter/drain

          -  Treatment with systemic antibiotics

          -  Able to consent

        Exclusion Criteria:

          -  Abscess(es) not amendable for an image guided drain placement.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paolo Goffredo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Granchi, MD</last_name>
    <phone>319-356-1339</phone>
    <email>thomas-granchi@uiowa.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Linda Ahrens</last_name>
    <phone>319-353-8435</phone>
    <email>linda-ahrens@uiowa.edu</email>
  </overall_contact_backup>
  <reference>
    <citation>Yoon YI, Hwang S, Cho YJ, Ha TY, Song GW, Jung DH. Therapeutic effect of trans-drain administration of antibiotics in patients showing intractable pancreatic leak-associated pus drainage after pancreaticoduodenectomy. Korean J Hepatobiliary Pancreat Surg. 2015 Feb;19(1):17-24. doi: 10.14701/kjhbps.2015.19.1.17. Epub 2015 Feb 28.</citation>
    <PMID>26155272</PMID>
  </reference>
  <reference>
    <citation>Sauermann R, Karch R, Kjellsson MC, Feurstein T, Püspök A, Langenberger H, Böhmdorfer M, Jäger W, Zeitlinger M. Good penetration of moxifloxacin into human abscesses. Pharmacology. 2012;90(3-4):146-50. doi: 10.1159/000341550. Epub 2012 Aug 3.</citation>
    <PMID>22868236</PMID>
  </reference>
  <reference>
    <citation>Sauermann R, Feurstein T, Karch R, Kjellsson MC, Jäger W, Böhmdorfer M, Püspök A, Langenberger H, Wild T, Winkler S, Zeitlinger M. Abscess penetration of cefpirome: concentrations and simulated pharmacokinetic profiles in pus. Eur J Clin Pharmacol. 2012 Oct;68(10):1419-23. doi: 10.1007/s00228-012-1270-1. Epub 2012 Mar 23.</citation>
    <PMID>22441316</PMID>
  </reference>
  <reference>
    <citation>Zimmerman LH, Tyburski JG, Glowniak J, Singla R, Lavery T, Nailor M, Stassinopoulus J, Hong K, Barshikar S, Dolman HS, Baylor AE, Wilson RF. Impact of evaluating antibiotic concentrations in abdominal abscesses percutaneously drained. Am J Surg. 2011 Mar;201(3):348-52; discussion 352. doi: 10.1016/j.amjsurg.2010.09.010.</citation>
    <PMID>21367377</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2017</study_first_submitted>
  <study_first_submitted_qc>March 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2018</study_first_posted>
  <last_update_submitted>March 22, 2018</last_update_submitted>
  <last_update_submitted_qc>March 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Paolo Goffredo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abdominal Abscess</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Clindamycin</mesh_term>
    <mesh_term>Gentamicins</mesh_term>
    <mesh_term>Clindamycin phosphate</mesh_term>
    <mesh_term>Clindamycin palmitate</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>At this point, there is no IPD sharing plan and not included in the consent process.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

